• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌的移植治疗。

Transplantation for lung cancer.

机构信息

Division of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.

出版信息

Curr Opin Organ Transplant. 2012 Oct;17(5):479-84. doi: 10.1097/MOT.0b013e328357fff6.

DOI:10.1097/MOT.0b013e328357fff6
PMID:22907541
Abstract

PURPOSE OF REVIEW

Recent advances have led to improved outcomes in lung transplantation. The International Society for Heart and Lung Transplantation Registry data have shown a steady increase in the number of cases performed annually. Although somewhat controversial, lung transplantation (LTx) for lung cancer has also slowly increased. The current role of LTx for malignant diseases and the management challenge of incidental lung cancer in the explanted lungs are reviewed herein.

RECENT FINDINGS

For a few particular scenarios (advanced multifocal bronchioloalveolar carcinoma causing chronic respiratory failure, end-stage lung disease concomitant with early stage lung cancer, and metastatic disease restricted to the lungs with the primary site controlled) in which nonsurgical alternatives fail to provide adequate palliation, LTx may be considered. Nevertheless, in order to achieve acceptable results, careful patient selection and staging are paramount. In patients with incidental bronchogenic carcinoma in the explanted lung following transplantation, the prognosis is mainly driven by the malignancy stage.

SUMMARY

LTx can be performed to treat malignant diseases with results approaching those for nonneoplastic indications, given that patients are carefully selected and staged. Although they have not been widely applied in the reported lung transplant literature, modalities such as endobronchial ultrasound and positron emission tomography scan are strongly encouraged and have the potential to further refine staging in this population.

摘要

目的综述

近年来,肺移植的疗效有所提高。国际心肺移植协会登记处的数据显示,每年进行的病例数量稳步增加。尽管存在一些争议,但肺癌的肺移植(LTx)也在缓慢增加。本文回顾了 LTx 治疗恶性疾病的当前作用,以及在移植肺中偶然发现的肺癌的管理挑战。

最近的发现

对于一些特殊情况(导致慢性呼吸衰竭的晚期多灶性细支气管肺泡癌、伴早期肺癌的终末期肺病和主要部位得到控制的肺部转移疾病),如果非手术方法无法提供充分的缓解,可考虑进行 LTx。然而,为了获得可接受的结果,仔细的患者选择和分期至关重要。在移植后切除的肺中偶然发现的支气管肺癌患者中,预后主要取决于恶性肿瘤的分期。

总结

如果患者经过仔细选择和分期,LTx 可用于治疗恶性疾病,其结果可与非肿瘤适应证相近。尽管在已报道的肺移植文献中尚未广泛应用,但强烈鼓励使用支气管内超声和正电子发射断层扫描等方法,它们有可能进一步完善这一人群的分期。

相似文献

1
Transplantation for lung cancer.肺癌的移植治疗。
Curr Opin Organ Transplant. 2012 Oct;17(5):479-84. doi: 10.1097/MOT.0b013e328357fff6.
2
Role of lung transplantation in the treatment of bronchogenic carcinomas for patients with end-stage pulmonary disease.肺移植在终末期肺病患者支气管源性癌治疗中的作用。
J Clin Oncol. 2004 Nov 1;22(21):4351-6. doi: 10.1200/JCO.2004.12.188.
3
Lung transplantation for non-small cell lung cancer and multifocal bronchioalveolar cell carcinoma.肺移植治疗非小细胞肺癌和多灶性细支气管肺泡细胞癌。
Lancet Oncol. 2018 Jul;19(7):e351-e358. doi: 10.1016/S1470-2045(18)30297-3. Epub 2018 Jun 29.
4
Lung transplantation for multifocal lung adenocarcinoma (multifocal lung carcinoma).多灶性肺腺癌(多灶性肺癌)的肺移植
Thorac Surg Clin. 2014 Nov;24(4):485-91. doi: 10.1016/j.thorsurg.2014.07.011. Epub 2014 Oct 23.
5
Bilateral lung transplant for bronchioloalveolar carcinoma: first case in China.细支气管肺泡癌双侧肺移植:中国首例
Exp Clin Transplant. 2012 Oct;10(5):519-21. doi: 10.6002/ect.2011.0186. Epub 2012 Jul 3.
6
Recurrence of bronchioloalveolar carcinoma in transplanted lungs.移植肺中细支气管肺泡癌的复发
N Engl J Med. 1999 Apr 8;340(14):1071-4. doi: 10.1056/NEJM199904083401403.
7
Outcomes for lung transplantation for lung cancer in the United Network for Organ Sharing Registry.美国器官共享联合网络注册中心肺癌肺移植的结果。
Ann Thorac Surg. 2012 Sep;94(3):935-40; discussion 940-1. doi: 10.1016/j.athoracsur.2012.04.069. Epub 2012 Jul 25.
8
With Comparable Outcomes, Should Early-Stage Lung Cancer Be a Contraindication to Lung Transplant?早期肺癌是否应成为肺移植的禁忌证?在结果可比的情况下
Ann Thorac Surg. 2024 Jul;118(1):261-267. doi: 10.1016/j.athoracsur.2023.09.002. Epub 2023 Sep 12.
9
[Lung transplantation for lung carcinoma: a case report and literature review].[肺癌肺移植:一例病例报告及文献综述]
Zhongguo Fei Ai Za Zhi. 2011 Jul;14(7):633-6. doi: 10.3779/j.issn.1009-3419.2011.07.14.
10
Incidental Lung Cancer of Explanted Lungs from Lung Transplant Recipients: Incidence, Characteristics, and 5-Year Survival.肺移植受体中肺移植后偶然发现的肺癌:发生率、特征和 5 年生存率。
Yonsei Med J. 2020 Nov;61(11):958-964. doi: 10.3349/ymj.2020.61.11.958.

引用本文的文献

1
Bilateral orthotopic lung transplantation for the patient with lung-limited invasive mucinous adenocarcinoma: a case-based literature review.肺局限性浸润性黏液腺癌患者的双侧原位肺移植:基于病例的文献综述
Oncologist. 2025 Aug 4;30(8). doi: 10.1093/oncolo/oyae263.
2
Primary graft dysfunction following lung transplantation: From pathogenesis to future frontiers.肺移植后的原发性移植肺功能障碍:从发病机制到未来前沿
World J Transplant. 2023 Mar 18;13(3):58-85. doi: 10.5500/wjt.v13.i3.58.
3
Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.
肺移植候选人选择的共识文件:国际心肺移植学会的更新。
J Heart Lung Transplant. 2021 Nov;40(11):1349-1379. doi: 10.1016/j.healun.2021.07.005. Epub 2021 Jul 24.
4
Pulmonary fibrosis combined with lung cancer following lung transplantation: should we do more?肺移植后合并肺癌的肺纤维化:我们是否应采取更多措施?
Transl Lung Cancer Res. 2021 Mar;10(3):1588-1593. doi: 10.21037/tlcr-21-46.
5
Lung cancer: a rare indication for, but frequent complication after lung transplantation.肺癌:肺移植的罕见适应证,但却是肺移植后常见的并发症。
J Thorac Dis. 2016 Nov;8(Suppl 11):S915-S924. doi: 10.21037/jtd.2016.11.05.
6
Overview of clinical lung transplantation.临床肺移植概述。
Cold Spring Harb Perspect Med. 2014 Jan 1;4(1):a015628. doi: 10.1101/cshperspect.a015628.